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Abstract
Background: Campylobacter is a leading cause of bacterial gastroenteritis, but sensitive diagnostic methods such as
culture are expensive and often not available in resource limited settings. Therefore, direct staining techniques have
been developed as a practical and economical alternative. We analyzed the impact of replacing Campylobacter
staining with culture for routine stool examinations in a private hospital in Chile.
Methods: From January to April 2014, a total of 750 consecutive stool samples were examined in parallel by Hucker
stain and Campylobacter culture. Isolation rates of Campylobacter were determined and the performance of staining
was evaluated against culture as the gold standard. Besides, isolation rates of Campylobacter and other enteric
pathogens were compared to those of past years.
Results: Campylobacter was isolated by culture in 46 of 750 (6.1 %) stool samples. Direct staining only identified three
samples as Campylobacter positive and reached sensitivity and specificity values of 6.5 and 100 %, respectively. In
comparison to staining-based detection rates of previous years, we observed a significant increase of Campylobacter
cases in our patients.
Conclusion: Direct staining technique for Campylobacter had a very low sensitivity compared to culture. Staining
methods might lead to a high rate of false negative results and an underestimation of the importance of
campylobacteriosis. With the inclusion of Campylobacter culture, this pathogen became a leading cause of intestinal
infection in our patient population.
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Background
The genus Campylobacter comprises fastidious S-shaped
or spiral gram-negative bacteria with a length of 0.5 to
5 μm, which are microaerophilic, non-spore-forming, and
mobile by the presence of a polar flagellum. Campylobac-
ter is among the most important causes of foodborne
infections causing human gastroenteritis worldwide [1].
Infections with this pathogen might be followed by severe
sequelae such as reactive arthritis, Guillain-Barré syndrome,
and irritable bowel syndrome [2]. Campylobacter species
are ubiquitous in the environment and the intestinal tracts
of a variety of free-living birds, wild and domestic food
animals, and pets [3, 4]. As an emerging zoonotic agent, it
is of growing public health importance and also affects
non-clinical areas such as food-production and animal
handling [1].
There has been a rise in the incidence of campylobacter-
iosis in the last ten years in most developed regions such
as North America, Europe, and Australia [5]. In South
America, the role of Campylobacter as an enteric patho-
gen is less clear, since epidemiological data are scant and
inconclusive [1, 5, 6]. In Chile, Campylobacter is a notifi-
able enteric pathogen. Recently, the National Reference
Laboratory (Instituto de Salud Pública, Santiago, Chile)
reported an average of 91 annual Campylobacter cases for
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the whole of Chile during 2005 to 2012, implicating inci-
dence rates of 0.1 to 0.6/100.000 [7]. In comparison, the
current rate in the USA is 13.5/100.000 [8]. A recent study
from southern Chile detected C. jejuni in 10 and 10.7 % of
diarrheic samples by culture and PCR, respectively [9].
Older reports from the 1980s and 1990s, which mainly
focused on pediatric populations, showed incidence rates
of 10 and 16 % in symptomatic children [10, 11].
Culture methods are the gold standard for the diagnosis
of intestinal Campylobacter infections. However, these
methods require special selective media incubated at 37°
and/or 42 ° C under microaerophilic conditions and are
therefore inconvenient and expensive [12]. As a conse-
quence, they are not included within the routine stool
workup of many non-industrialized countries including
Chile [7]. As a more economical alternative, direct stool
staining methods have been developed and currently, these
techniques are recommended in Chile for the routine
detection of Campylobacter in stool samples of patients
with acute gastroenteritis [13]. However, these methods are
insufficiently evaluated and have drawbacks such as oper-
ator dependency. Due to sensitivity problems [14], they
might underestimate the true incidence of this organism.
The aim of this study was to compare Campylobacter
detection rates by microscopic examination to those based
on culture in routine stool samples and to analyze the
possible impact of performing Campylobacter culture as a
routine method on the epidemiological data of campylo-
bacteriosis in our clinical setting.
Methods
The study was conducted between January and April 2014
in the Clinical Laboratory of Clínica Alemana in Santiago,
Chile. It utilized consecutive stool samples that were
tested as part of routine care, which included culture
methods for Salmonella, Shigella, Yersinia, and Vibrio, as
well as direct stain for Campylobacter. Samples consisted
of fresh stool, transported at ambient temperature and
processed within 2 h after collection. For culture and
enrichment, commercial selective media such as Mac
Conkey, Salmonella-Shigella agar, CIN, TCBS, selenite
broth, alkaline peptone water (all bioMérieux, l’Etoile,
France) were used following standard recommendations
[2, 15, 16]. Campylobacter staining was performed as
recommended in Chile [13] and previously described [14,
17]. In short, smears of undiluted stool were prepared
using a swab (155C, Copan, Brescia, Italy) and air dried.
Then, slides were flooded for 1–2 min with a monthly
prepared solution of equal parts of 1 % sodium bicarbon-
ate and commercial crystal violet solution (Color Gram 2
R1, bioMérieux). Slides were examined during routine
workflow by a trained technician (50 high power oil
immersion fields) for the presence of S-shaped or spiral
rods. For quality control, all positive or doubtful slides
were sent to the National Reference Laboratory. Each
sample was inoculated with a swab on Campylobacter
culture medium (Campylosel agar, bioMérieux), streaked
into 4 quadrants with a sterile loop and incubated at 42 °C
under microaerobic conditions (Anaerocult® C, Merck,
Darmstadt, Germany). Quality control for each batch of
culture medium was performed using C. jejuni ATCC
33291 (growth at 48 h) and E. coli ATCC 25922 (growth
inhibition) as recommended [18]. Campylobacter plates
were read after 48 h and suspicious colonies were further
identified by matrix-assisted laser desorption/ionization
time-of-flight (MALDI-TOF) technology using VITEK
MS (bioMérieux). Following surveillance regulations, all
enteropathogens were sent to the National Reference
Laboratory for confirmation and susceptibility testing.
Campylobacter strains were studied against ciprofloxacin,
erythromycin and tetracycline by E-Test (bioMérieux) on
blood Mueller-Hinton agar incubated for 24 h at 42 °C
under microaerobic conditions. Results were interpreted
according to CLSI guidelines [19].
The performance of Campylobacter staining technique
was evaluated using culture as gold standard. To estimate
the impact of culture methods on the detection of Cam-
pylobacter, isolation rates of all enteric bacterial pathogens
within the study period were compared to those of the
same time span of past years in our laboratory. These data
were obtained from the laboratory databases. To compare
isolation rates, 95 % confidence intervals were calculated
and the Z test for comparing two independent proportions
was applied. P values <0.05 were considered significant. For
statistical analysis, Clinical Calculator 1 (http://vassarstats.-
net) was used.
Results
A total of 750 stool samples were examined. In 96 of them
(12.8 %), bacterial pathogens were detected (Table 1). All
enteric pathogens were identified to the species level with
high identification scores (99.9 %) by Vitek MS.
Campylobacter culture was positive in 46 (6.1 %)
samples. The median age of the Campylobacter positive
patients was 12 years (range: 1 to 89). The majority (41/46;
89.1 %) of strains was C. jejuni, the other 10.9 % were C.
coli. Staining technique identified three samples as Cam-
pylobacter positive, all of which contained C. jejuni. Thus,
the Campylobacter detection rate using Hucker stain was
0.4 % (Table 1) with a sensitivity of 6.5 % (CI95 %: 1.7–
18.9) and a specificity of 100 % (CI95 %: 99.3–100). Positive
and negative predictive values for staining were 100 %
(CI95 % 31.0–100) and 94.2 % (CI95 % 92.3–95.8),
respectively.
The culture-based Campylobacter rate within our study
period (January to April 2014) was significantly higher than
the staining-based rates of previous years (Fig. 1). A com-
parison of detection rates of all bacterial enteropathogens
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identified in stool samples in our laboratory in the months
of January to April of 2010 to 2014 demonstrated a clear
change of the epidemiological relevance of Campylobacter
after the introduction of culture methods in 2014 (Fig. 2).
In the years 2010 to 2013, Salmonella was clearly the most
frequently isolated enteropathogen, whereas the other
bacterial causes were only rarely detected. In 2014, with
the introduction of Campylobacter culture, Campylobac-
ter became, together with Salmonella, the leading cause of
bacterial enteritis in our patient collective.
National Reference Laboratory studied fourteen of the
Campylobacter strains for antimicrobial susceptibility.
Of those, 13 (92.8 %) were susceptible to erythromycin,
whereas tetracycline- and ciprofloxacin-resistance was
detected in three (21.4 %) and five (35.7 %) of the iso-
lates, respectively.
Discussion
Campylobacter is a leading cause of gastrointestinal infec-
tions in industrialized and non-industrialized countries
[1]. Its clinical and epidemiological importance is under-
lined by the ubiquitous nature of the pathogen, the possi-
bility of severe post-infectious sequelae, and the increase
of its burden during the last decade. Unfortunately, under-
reporting of campylobacteriosis is common and in some
regions, the epidemiology of this infection is incompletely
understood [5].
In most South American countries, the epidemiological
role of Campylobacter as an enteric pathogen is unknown,
since systematic studies are scant and national surveil-
lance programs are mostly absent [1, 5]. The main reason
for this lack of data is that Campylobacter culture is
expensive or not available and therefore, rarely included in
the routine stool workup in microbiological laboratories
[14]. In Chile, enteric Campylobacter infections were
included in the national mandatory decree of active la-
boratory surveillance of enteropathogens in 1993 [7].
Since then, due to financial limitations, most Chilean la-
boratories adopted staining methods such as Hucker stain
as the routine diagnostic tool for Campylobacter as sug-
gested by local recommendations [13, 14]. The presented
study highlights a potential problem of this approach since
direct stool microscopy proved to have a very low and
insufficient sensitivity compared to culture. In a previous
study using the same technique in Chile, the sensitivity
Table 1 Number and rate of bacterial pathogens identified in
750 routine stool samples
Pathogen n Isolation rate (%) CI 95 %










Campylobacter (by culture) 46 6.1 4.6–8.1
C. jejuni 41
C. coli 5
Campylobacter spp. (by staining) 3 0.4 0.1–1.3
Yersinia enterocolitica 1 0.1 0.01–0.9
Vibrio parahaemolyticus 1 0.1 0.01–0.9
Total 96a 12.8 10.5–15.5
aIncluding one sample with double infection, C. jejuni and Y. enterocolitica
Fig. 1 Detection rates of Campylobacter in routine stool samples. Graph showing percentage of Campylobacter positive samples within January to
April of the respective year. Blue columns represent rates based on Campylobacter direct staining, orange column on Campylobacter culture. Black
bars indicate the 95 % confidence intervals. P values by Z test for comparing two independent proportions
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was higher, but the difference was not statistically signifi-
cant (37.5 %, CI95 % 16.3–64.1) [14]. Other studies using
different stains such as Gram, reported much higher
sensitivity values from 44 to 94 % [20–24]. Reasons for the
lower sensitivity in our study might be the use of a differ-
ent staining technique, diagnostic settings (study versus
routine conditions), study populations (children versus
adults), and technical problems with Campylobacter cul-
ture, especially in older reports or in studies from develop-
ing countries. A main obstacle is that direct staining
methods are highly operator dependent because they
require significant expertise [2]. Therefore, objective eval-
uations of the performance are difficult and some experts
discourage the routine use of these methods [15]. Another
obstacle for a standardization of these techniques is the
lack of protocols for quality control. External quality con-
trol programs offered from international institutions such
as the College of American Pathologists (CAP) do not
include direct Campylobacter staining. To overcome this
limitation, microscopists should regularly be re-trained
and tested. In accordance with other reports, the specifi-
city of Campylobacter staining in our study was high [14,
20–24]. Positive results therefore, provide rapid and clinic-
ally relevant information. Still, direct staining can only
serve as a supplemental test and should not replace Cam-
pylobacter culture.
Besides the costs, a drawback of Campylobacter culture
is the prolonged incubation period. Still, the optimum
time is controversial. While in North America, 72 h of
incubation are recommended [2], British and German
guidelines suggest shorter incubation periods of 40–48 h
[25, 26]. As a recent survey of more than 400 laboratories
in the USA revealed, most participants also used 48 h for
routine incubation for Campylobacter culture [27]. In our
study we incubated cultures for 48 h as currently recom-
mended by the Chilean consensus statement [13].
Culture-independent methods for Campylobacter diag-
nosis are commercially available in many countries in the
industrialized world. Such tests include the detection of
Campylobacter specific antigen and nucleic acids in stool
samples. Until now, these tests are insufficiently evaluated
to replace the traditional culture methods and do not serve
for susceptibility testing and public health surveillance
purposes [2]. The WHO encourages further research to
Fig. 2 Detection rates of enteric bacterial pathogens in routine stool samples. Graph showing percentage of enteropathogenic bacteria detected
in stool samples within January to April of the respective year. All numbers are based on culture techniques except Campylobacter rates of the
years 2010 to 2013, which are based on staining method
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validate the usefulness of these tests in low- and middle-
income countries [1]. A recent study with samples from
Tanzania, Bangladesh, and Peru showed higher Campylo-
bacter prevalence rates than with culture, but no clear asso-
ciation with diarrheal disease [28]. In Chile, PCR detected
higher prevalence of campylobacteriosis than culture, but
most of the additional cases were caused by emerging
Campylobacter species such as C. concisus [9]. To our opin-
ion, the introduction of such new culture-independent
techniques in countries with uncertain epidemiology such
as Chile seems problematic at present.
With the inclusion of culture methods in routine stool
examination during the study period, the Campylobacter
detection rate increased by more than 10-fold compared to
staining and was also significantly higher than in the same
time period of the previous years (Fig. 1). Since a compari-
son of the staining-based rates did not show any evidence
of an epidemiological change, we assume that the emer-
gence of Campylobacter was truly related to the implemen-
tation of the new diagnostic procedure. A comparison of
the detection rates of all bacterial enteropathogens during
the years of 2010 to 2014 revealed that after the inclusion
of culture, Campylobacter became a leading enteric patho-
gen with rates similar to those of Salmonella. This was a
surprising finding, since in the official surveillance reports
of recent years, Salmonella largely exceeds Campylobacter.
In 2011 and 2012, for example, the respective numbers of
cases were 3627 and 3076 for Salmonella, but only 170 and
136 for Campylobacter [7]. We believe that these extremely
low rates of Campylobacter isolates might rather reflect on
the insufficient diagnostic capacities to detect this pathogen
than on the true epidemiological situation. This misjudg-
ment and lack of reliable data leads to an underestimation
of the importance of Campylobacter and further ignorance
regarding its diagnosis - an epidemiological vicious circle.
To our opinion, the implementation of Campylobacter
culture as the routine diagnostic method in Chile is
recommendable, although an exact analysis of the cost-
effectiveness of this method is pending.
Matrix-assisted laser desorption/ionization time-of-
flight (MALDI TOF) proved to be a rapid, convenient,
and reliable diagnostic tool for Campylobacter species
identification. If available, this technology might help to
better understand the distribution of species other than
C. jejuni. In our study, C. coli was less frequently isolated
(5/46; 10.9 %) than previously reported in diarrhea cases
in southern Chile (27.7 %) [6].
Our data confirmed the high percentage of ciprofloxacin
resistance of Campylobacter jejuni in Chile, which has
previously been reported [29]. Surprisingly, one of the
strains was also resistant to erythromycin, which had not
been reported before in strains of human origin in Chile.
These findings support the need for routine Campylobac-
ter culture and for further surveillance of resistance.
The age distribution of our patients differed from older
data in Chile, which reported that the majority of cases
occurred in infants and preschool children [14], but was
in accordance with a more recent study from southern
Chile [9]. We observed a median age of 12 years without
predominance of children less than 5 years. This might be
explained by the high socioeconomic status of our patients
attending a private hospital, since in North America and
Europe campylobacteriosis in individuals older than ten
years was associated with higher socioeconomic condi-
tions [30].
Limitations of this study were that it covered only a
limited period of time and samples derived only from a
single clinical center. This might have aggravated the
operator dependency of the staining method. As a study
based on routine samples, the clinical data were limited.
Furthermore, we did not include the study of viral or
parasitic etiologies of enteritis.
Conclusions
Our study showed that with the inclusion of Campylobac-
ter culture in the routine bacteriological stool workup, this
pathogen became a leading cause of intestinal infection in
our patient population. Direct Campylobacter staining
methods, which have been promoted for resource-
limited settings, proved to be of low sensitivity and lead
to a significant underestimation of the incidence of
campylobacteriosis.
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